ANTIGENICS INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 5250
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
6284238 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methodsJun 06, 95Sep 04, 01[A61K]
5976860 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methodsMar 11, 96Nov 02, 99[C12N]
5650398 Drug delivery enhancement via modified saponinsJun 02, 95Jul 22, 97[A61K]
5583112 Saponin-antigen conjugates and the use thereofJul 02, 92Dec 10, 96[A61K]
5352449 Vaccine comprising recombinant feline leukemia antigen and saponin adjuvantApr 14, 92Oct 04, 94[A61K]
5273965 Methods for enhancing drug delivery with modified saponinsJul 02, 92Dec 28, 93[A61K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2007/0003,555 Heat shock protein binding fragments of CD91, and uses thereofAbandonedOct 07, 03Jan 04, 07[A61K, C07H, C12P, G01N, C07K]
7030094 Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21ExpiredJun 21, 02Apr 18, 06[A61K]
2005/0221,395 Methods and products based on oligomerization of stress proteinsAbandonedMar 14, 05Oct 06, 05[A61K, C12Q, G01N]
2005/0191,310 Novel compositions of saponin adjuvants and excipientsAbandonedOct 03, 03Sep 01, 05[A61K]
2004/0258,705 Use of lectins to promote oligomerization of glycoproteins and antigenic moleculesAbandonedFeb 27, 04Dec 23, 04[A61K]
2004/0115,737 Cd36 as a heat shock protein receptor and uses thereofAbandonedDec 24, 03Jun 17, 04[G01N]
2004/0101,532 Methods and compositions for heat shock protein mediated immunotherapy of melanomaAbandonedJan 02, 04May 27, 04[A61K]
2004/0071,656 Modulation of heat-shock-protein-based immunotherapiesAbandonedDec 23, 02Apr 15, 04[A61K]
2004/0052,812 Heat shock protein-based antiviral vaccinesAbandonedSep 05, 03Mar 18, 04[A61K]
2004/0043,419 Javelinization of protein antigens to heat shock proteinsAbandonedAug 13, 03Mar 04, 04[G01N, C07K]
2003/0190,333 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponinsAbandonedFeb 04, 02Oct 09, 03[A61K]
6524584 Saponin compositions and uses thereofExpiredMay 14, 01Feb 25, 03[A61K]
2002/0044,951 Isolated and purified nonpeptide antigens from mycobacterium tuberculosisAbandonedApr 04, 01Apr 18, 02[A61K]
2002/0037,290 Compositions comprising heat shock proteins or alpha(2) macroglobulin, antigenic molecules and saponins, and methods of use thereofAbandonedJul 20, 01Mar 28, 02[A61K]
2001/0034,330 Innate immunity-stimulating compositions of CpG and saponin and methods thereofAbandonedJan 12, 01Oct 25, 01[A61K]
5952232 Expandible microparticle intracellular delivery systemExpiredSep 17, 98Sep 14, 99[C12N]
5057540 Saponin adjuvantExpiredAug 27, 90Oct 15, 91[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.